3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Unknown
2
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
4
Sarcoma
2
Genitourinary
2
Head & Neck
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Conditions
Chordoma
2
Neoplasms
1
Interventions
Doxorubicin
25
Radiotherapy
16
apatinib
15
Cyclophosphamide
15
Ifosfamide
13
anlotinib
12
camrelizumab
10
Temozolomide
9
Imatinib Mesylate
9
Vincristine
8
Surgical Procedures, Operative
7
Neoadjuvant Therapy
7
Methotrexate
7
Drug Therapy
7
Dactinomycin
5
Blood Specimen Collection
5
fludarabine phosphate
4
Paclitaxel
4
Immune Checkpoint Inhibitors
4
Etoposide
4
Docetaxel
4
Carboplatin
4
toripalimab
3
pembrolizumab
3
Trabectedin
3
Topotecan
3
Surveys and Questionnaires
3
Radiation Dose Hypofractionation
3
Nivolumab
3
Melphalan
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Protons
×
Sarcoma
×
Clear all
NCT01811394
2023-12-06
ISAC
Heidelberg University
Phase 2
Unknown
100 enrolled
NCT01182779
2010-08-17
HIT-1
Heidelberg University
Phase 3
Unknown
319 enrolled